BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12480961)

  • 1. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.
    Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E
    Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.
    Adams J; Odoni G; Ogata H; Viedt C; Amann K; Ritz E; Orth SR
    Nephrol Dial Transplant; 2002 May; 17(5):780-7. PubMed ID: 11981063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
    Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A
    Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibition and endothelin antagonism for endothelial dysfunction in heart failure: mono-or combination therapy.
    Bauersachs J; Fraccarollo D; Schäfer A; Ertl G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):594-600. PubMed ID: 12352322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of the endothelin(A) receptor antagonist LU 135252 and the angiotensin-converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type I diabetes mellitus rat model.
    Dhein S; Hochreuther S; Aus Dem Spring C; Bollig K; Hufnagel C; Raschack M
    J Pharmacol Exp Ther; 2000 May; 293(2):351-9. PubMed ID: 10773002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
    Hofman C; Gabai E; Peleg E; Munter K; Rosenthal T
    Blood Press; 2005; 14(2):114-9. PubMed ID: 16036489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trandolapril and endothelin antagonist LU-135252 in the treatment of the fructose-induced hypertensive, hyperinsulinemic, hypertriglyceridemic rat.
    Ezra-Nimni O; Ezra D; Peleg E; Munter K; Rosenthal T
    Am J Hypertens; 2003 Apr; 16(4):324-8. PubMed ID: 12670751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15-month-old spontaneously hypertensive rats: effects on coronary resistance and ventricular compliance in normoxia and anoxia.
    Amrani FC; Cheaw SL; Chevalier B; Paolaggi F; Jouquey S; Hamon G; Swynghedauw B
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):155-65. PubMed ID: 7511729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.
    Gross ML; Ritz E; Schoof A; Helmke B; Parkman A; Tulp O; Münter K; Amann K
    Lab Invest; 2003 Sep; 83(9):1267-77. PubMed ID: 13679434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of endothelin blockade on early cardiovascular remodeling in the one-clip-two-kidney hypertension of the rat.
    Saam T; Ehmke H; Haas C; Ritz E; Amann K
    Kidney Blood Press Res; 2003; 26(5-6):325-32. PubMed ID: 14610336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged blockade of endothelin ET(A) receptors decreases vascular reactivity in the aorta of spontaneously hypertensive rats in vitro.
    Iglarz M; Lévy BI; Henrion D
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):354-8. PubMed ID: 10470992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment of spontaneously hypertensive rats with the angiotensin-converting enzyme inhibitor trandolapril and the calcium antagonist verapamil on the sensitivity of glucose metabolism to insulin in rat soleus muscle in vitro.
    Leighton B; Sanderson AL; Young ME; Radda GK; Boehm EA; Clark JF
    Diabetes; 1996 Jan; 45 Suppl 1():S120-4. PubMed ID: 8529792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
    Fraccarollo D; Bauersachs J; Kellner M; Galuppo P; Ertl G
    Cardiovasc Res; 2002 Apr; 54(1):85-94. PubMed ID: 12062365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model.
    Orth SR; Odoni G; Amann K; Strzelczyk P; Raschack M; Ritz E
    J Am Soc Nephrol; 1999 Feb; 10(2):387-91. PubMed ID: 10215340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated vascular angiotensin converting enzyme mediates increased neointima formation after balloon injury in spontaneously hypertensive rats.
    Jandeleit-Dahm K; Burrell LM; Johnston CI; Koch KM
    J Hypertens; 1997 Jun; 15(6):643-50. PubMed ID: 9218184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic blockade of endothelin ETA receptors improves flow dependent dilation in resistance arteries of hypertensive rats.
    Iglarz M; Matrougui K; Lévy BI; Henrion D
    Cardiovasc Res; 1998 Sep; 39(3):657-64. PubMed ID: 9861309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of trandolapril on the lifespan of a severe hypertensive model.
    Takai S; Sakonjo H; Miyazaki M
    Hypertens Res; 2001 Sep; 24(5):559-64. PubMed ID: 11675951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of anti-hypertensive therapy on the structural, mechanical and metabolic properties of the rat aorta.
    Clark JF; Radda GK; Boehm EA
    J Muscle Res Cell Motil; 2000 Apr; 21(3):255-67. PubMed ID: 10952173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.